NEWS      WELCOME      CONTACT EMN      EMN SO      EMN TRIALS      EMN TRIAL GROUP      EMN BIOLOGY GROUP      LOGIN      MSCNET

 Updated on: Jan 9 2014

EMN Trials

 

 is titled:

 

"A Randomized Phase III Study to Compare Bortezomib, Melphalan, Prednisone (VMP) With High Dose Melphalan Followed by Bortezomib, Lenalidomide, Dexamethasone (VRD) Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma".
  

Read a brief summary of the study here

 

The trial is registered on Clinicaltrial.gov

 



26.10.2016

 

DMSG Scientific Symposium - see programme here 

 

See slides from the presentation: 

The Nordic Experience
 - MRD analysis by flowcytometry. Professor Hans Erik Johnsen, Department Hematology, Aalborg University Hospital

10 October 2012

 

Dear NMSG members and EMN-02 participants.

 

On behalf of the EMN02 study group a Flow Cytometry training session was held on 19 November 2012 for all who did not have the chance to participate so far.  

Read announcement/programme here.

  

Sincerely
Hans E Johnsen and Alexander Schmitz

EMN-02 Nordic Biobank Center & MRD Central Laboratory

 

 

 21 February 2012

 

Dear NMSG members and EMN-02 participants.

                     

Flow cytometry specialists were invited to the latest Flow Cytometry training session on 14 March 2012 in Aalborg, Denmark. The session was related to the MRD sub study of the EMN-02 trial!

 

 

Read announcement/programme here.

 

 

Sincerely
Hans E Johnsen and Alexander Schmitz

 

 

 

 

Secr. Hans E. Johnsen | Depart. of Haematology | Aalborg University Hospital | Sdr. Skovvej 15 | DK-9000 Aalborg | Denmark | T:+45 9766 3871 | F:+45 9766 6369